Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer
Rationale and Objectives The aim of this prospective study was to investigate using multiparametric and multinuclear magnetic resonance imaging during preoperative systemic therapy for locally advanced breast cancer. Materials and Methods Women with operable stage 2 or 3 breast cancer who received p...
Gespeichert in:
Veröffentlicht in: | Academic radiology 2010-12, Vol.17 (12), p.1477-1485 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1485 |
---|---|
container_issue | 12 |
container_start_page | 1477 |
container_title | Academic radiology |
container_volume | 17 |
creator | Jacobs, Michael A., PhD Stearns, Vered, MD Wolff, Antonio C., MD Macura, Katarzyna, MD, PhD Argani, Pedram, MD Khouri, Nagi, MD Tsangaris, Theodore, MD Barker, Peter B., DPhil Davidson, Nancy E., MD Bhujwalla, Zaver M., PhD Bluemke, David A., MD, PhD Ouwerkerk, Ronald, PhD |
description | Rationale and Objectives The aim of this prospective study was to investigate using multiparametric and multinuclear magnetic resonance imaging during preoperative systemic therapy for locally advanced breast cancer. Materials and Methods Women with operable stage 2 or 3 breast cancer who received preoperative systemic therapy were studied using dynamic contrast-enhanced magnetic resonance imaging, magnetic resonance spectroscopy, and23 Na magnetic resonance. Quantitative metrics of choline peak signal-to-noise ratio, total tissue sodium concentration, tumor volumes, and Response Evaluation Criteria in Solid Tumors were determined and compared to final pathologic results using receiver-operating characteristic analysis. Hormonal markers were investigated. Statistical significance was set at P < .05. Results Eighteen eligible women were studied. Fifteen responded to therapy, four (22%) with pathologic complete response and 11 (61%) with pathologic partial response. Three patients (17%) had no response. Among estrogen receptor–positive, HER2-positive, and triple-negative phenotypes, observed frequencies of pathologic complete response, pathologic partial response, and no response were 2, 5, and 0; 1, 4, and 0; and 1, 1, and 3, respectively. Responders (pathologic complete response and pathologic partial response) had the largest reductions in choline signal-to-noise ratio (35%, from 7.2 ± 2.3 to 4.6 ± 2; P < .01) compared to nonresponders (11%, from 8.4 ± 2.7 to 7.5 ± 3.6; P = .13) after the first cycle. Total tissue sodium concentration significantly decreased in responders (27%, from 66 ± 18 to 48.4 ± 8 mmol/L; P = .01), while there was little change in nonresponders (51.7 ± 7.6 to 56.5 ± 1.6 mmol/L; P = .50). Lesion volume decreased in responders (40%, from 78 ± 78 to 46 ± 51 mm3 ; P = .01) and nonresponders (21%, from 100 ± 104 to 79.2 ± 87 mm3 ; P = .23) after the first cycle. The largest reduction in Response Evaluation Criteria in Solid Tumors occurred after the first treatment in responders (18%, from 24.5 ± 20 to 20.2 ± 18 mm; P = .01), with a slight decrease in tumor diameter noted in nonresponders (17%, from 23 ± 19 to 19.2 ± 19.1 mm; P = .80). Conclusions Multiparametric and multinuclear imaging parameters were significantly reduced after the first cycle of preoperative systemic therapy in responders, specifically, choline signal-to-noise ratio and sodium. These new surrogate radiologic biomarkers maybe able to predict and provide a platform for |
doi_str_mv | 10.1016/j.acra.2010.07.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3401079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1076633210004113</els_id><sourcerecordid>763165337</sourcerecordid><originalsourceid>FETCH-LOGICAL-c575t-66d5454b0f82775eb4156e2fd9283aa2cb699d417737e9c18c061c5f1241f9163</originalsourceid><addsrcrecordid>eNp9Ul1v0zAUjRATG4M_wAPyGyCR4o_ETqRp0qiATWoBMXi2XOemdUnsYDuV-n_4oTh0mxgPe_K1fc659jk3y14QPCOY8HfbmdJezShOB1jMMK4fZSekElVe4II_TjUWPOeM0ePsaQhbjEnJK_YkO6a44kxQcpL9Xo5dNIPyqofojUZLtbYQU_ENgrPKakBXvVobu36LrgfQ0bug3bBHyjboL9mOugPl0WvK0Gf15haOls6a6PxUuhZ99eAG8CqaHaD5BnoXN2mbhFrn0cJp1XV7dNHsppYNeu9BhYjm084_y45a1QV4frOeZj8-fvg-v8wXXz5dzS8WuS5FGXPOm7IoixVuKypECasi_Rdo29S0YkpRveJ13RRECCag1qTSmBNdtoQWpK0JZ6fZ-UF3GFc9NBps9KqTgze98nvplJH3b6zZyLXbSVakDESdBF7dCHj3a4QQZW-Chq5TFtwYpOCM8JIxkZD0gNTJz-ChvetCsJzSlVs5pSundCUWMqWbSC__fd8d5TbOBDg7ACC5tDPgZdAGJkONT9HJxpmH9c__o-vOWJOi-Ql7CFs3epv8l0QGKrG8nuZrGi-CMS4IYewPStDNzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763165337</pqid></control><display><type>article</type><title>Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Jacobs, Michael A., PhD ; Stearns, Vered, MD ; Wolff, Antonio C., MD ; Macura, Katarzyna, MD, PhD ; Argani, Pedram, MD ; Khouri, Nagi, MD ; Tsangaris, Theodore, MD ; Barker, Peter B., DPhil ; Davidson, Nancy E., MD ; Bhujwalla, Zaver M., PhD ; Bluemke, David A., MD, PhD ; Ouwerkerk, Ronald, PhD</creator><creatorcontrib>Jacobs, Michael A., PhD ; Stearns, Vered, MD ; Wolff, Antonio C., MD ; Macura, Katarzyna, MD, PhD ; Argani, Pedram, MD ; Khouri, Nagi, MD ; Tsangaris, Theodore, MD ; Barker, Peter B., DPhil ; Davidson, Nancy E., MD ; Bhujwalla, Zaver M., PhD ; Bluemke, David A., MD, PhD ; Ouwerkerk, Ronald, PhD</creatorcontrib><description>Rationale and Objectives The aim of this prospective study was to investigate using multiparametric and multinuclear magnetic resonance imaging during preoperative systemic therapy for locally advanced breast cancer. Materials and Methods Women with operable stage 2 or 3 breast cancer who received preoperative systemic therapy were studied using dynamic contrast-enhanced magnetic resonance imaging, magnetic resonance spectroscopy, and23 Na magnetic resonance. Quantitative metrics of choline peak signal-to-noise ratio, total tissue sodium concentration, tumor volumes, and Response Evaluation Criteria in Solid Tumors were determined and compared to final pathologic results using receiver-operating characteristic analysis. Hormonal markers were investigated. Statistical significance was set at P < .05. Results Eighteen eligible women were studied. Fifteen responded to therapy, four (22%) with pathologic complete response and 11 (61%) with pathologic partial response. Three patients (17%) had no response. Among estrogen receptor–positive, HER2-positive, and triple-negative phenotypes, observed frequencies of pathologic complete response, pathologic partial response, and no response were 2, 5, and 0; 1, 4, and 0; and 1, 1, and 3, respectively. Responders (pathologic complete response and pathologic partial response) had the largest reductions in choline signal-to-noise ratio (35%, from 7.2 ± 2.3 to 4.6 ± 2; P < .01) compared to nonresponders (11%, from 8.4 ± 2.7 to 7.5 ± 3.6; P = .13) after the first cycle. Total tissue sodium concentration significantly decreased in responders (27%, from 66 ± 18 to 48.4 ± 8 mmol/L; P = .01), while there was little change in nonresponders (51.7 ± 7.6 to 56.5 ± 1.6 mmol/L; P = .50). Lesion volume decreased in responders (40%, from 78 ± 78 to 46 ± 51 mm3 ; P = .01) and nonresponders (21%, from 100 ± 104 to 79.2 ± 87 mm3 ; P = .23) after the first cycle. The largest reduction in Response Evaluation Criteria in Solid Tumors occurred after the first treatment in responders (18%, from 24.5 ± 20 to 20.2 ± 18 mm; P = .01), with a slight decrease in tumor diameter noted in nonresponders (17%, from 23 ± 19 to 19.2 ± 19.1 mm; P = .80). Conclusions Multiparametric and multinuclear imaging parameters were significantly reduced after the first cycle of preoperative systemic therapy in responders, specifically, choline signal-to-noise ratio and sodium. These new surrogate radiologic biomarkers maybe able to predict and provide a platform for potential adaptive therapy in patients.</description><identifier>ISSN: 1076-6332</identifier><identifier>EISSN: 1878-4046</identifier><identifier>DOI: 10.1016/j.acra.2010.07.009</identifier><identifier>PMID: 20863721</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>23Na ; Adolescent ; Adult ; advanced cancer ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols ; Breast ; Breast Neoplasms - diagnostic imaging ; Breast Neoplasms - drug therapy ; Breast Neoplasms - surgery ; Female ; Humans ; Magnetic Resonance Imaging ; Middle Aged ; Neoplasm Staging ; Prospective Studies ; proton ; Radiography ; Radiology ; Sodium ; sodium MR ; spectroscopy</subject><ispartof>Academic radiology, 2010-12, Vol.17 (12), p.1477-1485</ispartof><rights>AUR</rights><rights>2010 AUR</rights><rights>Copyright © 2010 AUR. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c575t-66d5454b0f82775eb4156e2fd9283aa2cb699d417737e9c18c061c5f1241f9163</citedby><cites>FETCH-LOGICAL-c575t-66d5454b0f82775eb4156e2fd9283aa2cb699d417737e9c18c061c5f1241f9163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.acra.2010.07.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20863721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jacobs, Michael A., PhD</creatorcontrib><creatorcontrib>Stearns, Vered, MD</creatorcontrib><creatorcontrib>Wolff, Antonio C., MD</creatorcontrib><creatorcontrib>Macura, Katarzyna, MD, PhD</creatorcontrib><creatorcontrib>Argani, Pedram, MD</creatorcontrib><creatorcontrib>Khouri, Nagi, MD</creatorcontrib><creatorcontrib>Tsangaris, Theodore, MD</creatorcontrib><creatorcontrib>Barker, Peter B., DPhil</creatorcontrib><creatorcontrib>Davidson, Nancy E., MD</creatorcontrib><creatorcontrib>Bhujwalla, Zaver M., PhD</creatorcontrib><creatorcontrib>Bluemke, David A., MD, PhD</creatorcontrib><creatorcontrib>Ouwerkerk, Ronald, PhD</creatorcontrib><title>Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer</title><title>Academic radiology</title><addtitle>Acad Radiol</addtitle><description>Rationale and Objectives The aim of this prospective study was to investigate using multiparametric and multinuclear magnetic resonance imaging during preoperative systemic therapy for locally advanced breast cancer. Materials and Methods Women with operable stage 2 or 3 breast cancer who received preoperative systemic therapy were studied using dynamic contrast-enhanced magnetic resonance imaging, magnetic resonance spectroscopy, and23 Na magnetic resonance. Quantitative metrics of choline peak signal-to-noise ratio, total tissue sodium concentration, tumor volumes, and Response Evaluation Criteria in Solid Tumors were determined and compared to final pathologic results using receiver-operating characteristic analysis. Hormonal markers were investigated. Statistical significance was set at P < .05. Results Eighteen eligible women were studied. Fifteen responded to therapy, four (22%) with pathologic complete response and 11 (61%) with pathologic partial response. Three patients (17%) had no response. Among estrogen receptor–positive, HER2-positive, and triple-negative phenotypes, observed frequencies of pathologic complete response, pathologic partial response, and no response were 2, 5, and 0; 1, 4, and 0; and 1, 1, and 3, respectively. Responders (pathologic complete response and pathologic partial response) had the largest reductions in choline signal-to-noise ratio (35%, from 7.2 ± 2.3 to 4.6 ± 2; P < .01) compared to nonresponders (11%, from 8.4 ± 2.7 to 7.5 ± 3.6; P = .13) after the first cycle. Total tissue sodium concentration significantly decreased in responders (27%, from 66 ± 18 to 48.4 ± 8 mmol/L; P = .01), while there was little change in nonresponders (51.7 ± 7.6 to 56.5 ± 1.6 mmol/L; P = .50). Lesion volume decreased in responders (40%, from 78 ± 78 to 46 ± 51 mm3 ; P = .01) and nonresponders (21%, from 100 ± 104 to 79.2 ± 87 mm3 ; P = .23) after the first cycle. The largest reduction in Response Evaluation Criteria in Solid Tumors occurred after the first treatment in responders (18%, from 24.5 ± 20 to 20.2 ± 18 mm; P = .01), with a slight decrease in tumor diameter noted in nonresponders (17%, from 23 ± 19 to 19.2 ± 19.1 mm; P = .80). Conclusions Multiparametric and multinuclear imaging parameters were significantly reduced after the first cycle of preoperative systemic therapy in responders, specifically, choline signal-to-noise ratio and sodium. These new surrogate radiologic biomarkers maybe able to predict and provide a platform for potential adaptive therapy in patients.</description><subject>23Na</subject><subject>Adolescent</subject><subject>Adult</subject><subject>advanced cancer</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Breast</subject><subject>Breast Neoplasms - diagnostic imaging</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Prospective Studies</subject><subject>proton</subject><subject>Radiography</subject><subject>Radiology</subject><subject>Sodium</subject><subject>sodium MR</subject><subject>spectroscopy</subject><issn>1076-6332</issn><issn>1878-4046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Ul1v0zAUjRATG4M_wAPyGyCR4o_ETqRp0qiATWoBMXi2XOemdUnsYDuV-n_4oTh0mxgPe_K1fc659jk3y14QPCOY8HfbmdJezShOB1jMMK4fZSekElVe4II_TjUWPOeM0ePsaQhbjEnJK_YkO6a44kxQcpL9Xo5dNIPyqofojUZLtbYQU_ENgrPKakBXvVobu36LrgfQ0bug3bBHyjboL9mOugPl0WvK0Gf15haOls6a6PxUuhZ99eAG8CqaHaD5BnoXN2mbhFrn0cJp1XV7dNHsppYNeu9BhYjm084_y45a1QV4frOeZj8-fvg-v8wXXz5dzS8WuS5FGXPOm7IoixVuKypECasi_Rdo29S0YkpRveJ13RRECCag1qTSmBNdtoQWpK0JZ6fZ-UF3GFc9NBps9KqTgze98nvplJH3b6zZyLXbSVakDESdBF7dCHj3a4QQZW-Chq5TFtwYpOCM8JIxkZD0gNTJz-ChvetCsJzSlVs5pSundCUWMqWbSC__fd8d5TbOBDg7ACC5tDPgZdAGJkONT9HJxpmH9c__o-vOWJOi-Ql7CFs3epv8l0QGKrG8nuZrGi-CMS4IYewPStDNzg</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Jacobs, Michael A., PhD</creator><creator>Stearns, Vered, MD</creator><creator>Wolff, Antonio C., MD</creator><creator>Macura, Katarzyna, MD, PhD</creator><creator>Argani, Pedram, MD</creator><creator>Khouri, Nagi, MD</creator><creator>Tsangaris, Theodore, MD</creator><creator>Barker, Peter B., DPhil</creator><creator>Davidson, Nancy E., MD</creator><creator>Bhujwalla, Zaver M., PhD</creator><creator>Bluemke, David A., MD, PhD</creator><creator>Ouwerkerk, Ronald, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20101201</creationdate><title>Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer</title><author>Jacobs, Michael A., PhD ; Stearns, Vered, MD ; Wolff, Antonio C., MD ; Macura, Katarzyna, MD, PhD ; Argani, Pedram, MD ; Khouri, Nagi, MD ; Tsangaris, Theodore, MD ; Barker, Peter B., DPhil ; Davidson, Nancy E., MD ; Bhujwalla, Zaver M., PhD ; Bluemke, David A., MD, PhD ; Ouwerkerk, Ronald, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c575t-66d5454b0f82775eb4156e2fd9283aa2cb699d417737e9c18c061c5f1241f9163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>23Na</topic><topic>Adolescent</topic><topic>Adult</topic><topic>advanced cancer</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Breast</topic><topic>Breast Neoplasms - diagnostic imaging</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Prospective Studies</topic><topic>proton</topic><topic>Radiography</topic><topic>Radiology</topic><topic>Sodium</topic><topic>sodium MR</topic><topic>spectroscopy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacobs, Michael A., PhD</creatorcontrib><creatorcontrib>Stearns, Vered, MD</creatorcontrib><creatorcontrib>Wolff, Antonio C., MD</creatorcontrib><creatorcontrib>Macura, Katarzyna, MD, PhD</creatorcontrib><creatorcontrib>Argani, Pedram, MD</creatorcontrib><creatorcontrib>Khouri, Nagi, MD</creatorcontrib><creatorcontrib>Tsangaris, Theodore, MD</creatorcontrib><creatorcontrib>Barker, Peter B., DPhil</creatorcontrib><creatorcontrib>Davidson, Nancy E., MD</creatorcontrib><creatorcontrib>Bhujwalla, Zaver M., PhD</creatorcontrib><creatorcontrib>Bluemke, David A., MD, PhD</creatorcontrib><creatorcontrib>Ouwerkerk, Ronald, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Academic radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jacobs, Michael A., PhD</au><au>Stearns, Vered, MD</au><au>Wolff, Antonio C., MD</au><au>Macura, Katarzyna, MD, PhD</au><au>Argani, Pedram, MD</au><au>Khouri, Nagi, MD</au><au>Tsangaris, Theodore, MD</au><au>Barker, Peter B., DPhil</au><au>Davidson, Nancy E., MD</au><au>Bhujwalla, Zaver M., PhD</au><au>Bluemke, David A., MD, PhD</au><au>Ouwerkerk, Ronald, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer</atitle><jtitle>Academic radiology</jtitle><addtitle>Acad Radiol</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>17</volume><issue>12</issue><spage>1477</spage><epage>1485</epage><pages>1477-1485</pages><issn>1076-6332</issn><eissn>1878-4046</eissn><abstract>Rationale and Objectives The aim of this prospective study was to investigate using multiparametric and multinuclear magnetic resonance imaging during preoperative systemic therapy for locally advanced breast cancer. Materials and Methods Women with operable stage 2 or 3 breast cancer who received preoperative systemic therapy were studied using dynamic contrast-enhanced magnetic resonance imaging, magnetic resonance spectroscopy, and23 Na magnetic resonance. Quantitative metrics of choline peak signal-to-noise ratio, total tissue sodium concentration, tumor volumes, and Response Evaluation Criteria in Solid Tumors were determined and compared to final pathologic results using receiver-operating characteristic analysis. Hormonal markers were investigated. Statistical significance was set at P < .05. Results Eighteen eligible women were studied. Fifteen responded to therapy, four (22%) with pathologic complete response and 11 (61%) with pathologic partial response. Three patients (17%) had no response. Among estrogen receptor–positive, HER2-positive, and triple-negative phenotypes, observed frequencies of pathologic complete response, pathologic partial response, and no response were 2, 5, and 0; 1, 4, and 0; and 1, 1, and 3, respectively. Responders (pathologic complete response and pathologic partial response) had the largest reductions in choline signal-to-noise ratio (35%, from 7.2 ± 2.3 to 4.6 ± 2; P < .01) compared to nonresponders (11%, from 8.4 ± 2.7 to 7.5 ± 3.6; P = .13) after the first cycle. Total tissue sodium concentration significantly decreased in responders (27%, from 66 ± 18 to 48.4 ± 8 mmol/L; P = .01), while there was little change in nonresponders (51.7 ± 7.6 to 56.5 ± 1.6 mmol/L; P = .50). Lesion volume decreased in responders (40%, from 78 ± 78 to 46 ± 51 mm3 ; P = .01) and nonresponders (21%, from 100 ± 104 to 79.2 ± 87 mm3 ; P = .23) after the first cycle. The largest reduction in Response Evaluation Criteria in Solid Tumors occurred after the first treatment in responders (18%, from 24.5 ± 20 to 20.2 ± 18 mm; P = .01), with a slight decrease in tumor diameter noted in nonresponders (17%, from 23 ± 19 to 19.2 ± 19.1 mm; P = .80). Conclusions Multiparametric and multinuclear imaging parameters were significantly reduced after the first cycle of preoperative systemic therapy in responders, specifically, choline signal-to-noise ratio and sodium. These new surrogate radiologic biomarkers maybe able to predict and provide a platform for potential adaptive therapy in patients.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20863721</pmid><doi>10.1016/j.acra.2010.07.009</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1076-6332 |
ispartof | Academic radiology, 2010-12, Vol.17 (12), p.1477-1485 |
issn | 1076-6332 1878-4046 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3401079 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | 23Na Adolescent Adult advanced cancer Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Breast Breast Neoplasms - diagnostic imaging Breast Neoplasms - drug therapy Breast Neoplasms - surgery Female Humans Magnetic Resonance Imaging Middle Aged Neoplasm Staging Prospective Studies proton Radiography Radiology Sodium sodium MR spectroscopy |
title | Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23 Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T06%3A56%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiparametric%20Magnetic%20Resonance%20Imaging,%20Spectroscopy%20and%20Multinuclear%20(23%20Na)%20Imaging%20Monitoring%20of%20Preoperative%20Chemotherapy%20for%20Locally%20Advanced%20Breast%20Cancer&rft.jtitle=Academic%20radiology&rft.au=Jacobs,%20Michael%20A.,%20PhD&rft.date=2010-12-01&rft.volume=17&rft.issue=12&rft.spage=1477&rft.epage=1485&rft.pages=1477-1485&rft.issn=1076-6332&rft.eissn=1878-4046&rft_id=info:doi/10.1016/j.acra.2010.07.009&rft_dat=%3Cproquest_pubme%3E763165337%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=763165337&rft_id=info:pmid/20863721&rft_els_id=1_s2_0_S1076633210004113&rfr_iscdi=true |